Germany says Cosentyx shows no added benefit for psoriatic arthritis.

[mataribot]

Jim, I agree with being glass half full people, but if you are assessing the efficacy of drugs you cannot behave like a wrinkle cream spruiker. Dont think that a company would not fudge data to get its product to market and make it out to be better than the competition.

They already do this by running multiple phase 2 and 3 trials to get the results they want. The go to drug for psoriasis is Stelara - that is why drug manufacturers are testing their products against Stelara. We have reasonable amount evidence that consentyx helps PsA and AS. Is the results as good as TNFs? Who cares. Consentyx is a new product and at least for PsA is never going to be first in line treatment. This is about giving people opinions for this disease when they fail others such as TNFs.

This drug is expensive, and I don't blame anyone for not wanting to pay the high price. However, we can stop all the political nonsense and excuses. Their punch line should be "The price to performance ratio isn't as good as some of current medication. Therefore we will approve the request."